Microbix Biosystems Inc.

About Microbix Biosystems Inc.

Microbix Biosystems Inc. is a recognized leader in infectious disease diagnostics since 1985, committed to advancing diagnostic precision through expertise and advanced biological and technological solutions. Their mission is to enhance infectious disease detection, improve understanding, and transform global healthcare by redefining standards in diagnostics, research, and development.

Products & Services

Reference Materials (QUANTDx™):Proprietary materials for diagnostic assay development and validation.

Antigens:Extensive portfolio of viral, bacterial, and parasitic antigens for diagnostic tests and research in fields like epidemiology, virology, and immunology. Includes categories such as Childhood Disease, Dengue, STI, ToRCH, and Respiratory Antigens.

Quality assessment products designed to emulate patient samples using native pathogens or synthetic genomes for precision in diagnostics. Panels include Respiratory Viral, STI, HPV, Gastrointestinal, Genital Ulcer, and Vaginal Infections.

DxTM™ Viral Transport Medium:An IVD medical device for secure specimen collection and transport, available only in Canada.

Control Elution Buffer:Stable sample elution buffer for control swab formulations used in diagnostic tests.

Kinlytic (Urokinase):A product for specific medical applications (details not fully specified in content).

Vial Filling Services:Aseptic custom filling services for pilot or commercial scale needs, with capacities of 10,000 or 60,000 vials per day.

ONBOARDx™ RUO Kits:Kits for research use only, including samples from SARS-CoV-2, Respiratory, and HPV panels, with custom options available.

Specialties

Infectious Disease Diagnostics Diagnostic Assay Development Quality Assessment Products (QAPs) Antigen Production Viral Transport Media Custom Vial Filling Services

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Warrant Exercise T: - FT: Warrant Exercise	A: 1800000 MR: - FA: C$ 2.4 million FAN: 1800000	D: 2025-02-04 FD: 2025-02-04	1 investors
2	RT: Grant and Loan T: - FT: Grant and Loan	A: 1680000 MR: - FA: $840,000 grant and $840,000 loan FAN: 1680000	D: 2023-03-20 FD: 2023-03-20	2 investors

Warrant Exercise Latest

2025-02-04

$1.8M

1 investor (Pro only)

Grant and Loan 2023-03-20

$1.7M

View 1 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

C

Cameron Groome

CEO

J

Joe Renner

DIRECTOR

M

Mark A. Cochran

DIRECTOR

M

Martin Marino

CHAIRMAN OF THE BOARD

P

Peter M. Blecher

DIRECTOR

V

Vaughn C. Embro-Pantalony

DIRECTOR

View 12 more team members with Pro

Unlock Full Team Directory

Recent News